Apolipoprotein E polymorphisms and concentration in chronic diseases and drug responses (Q34093070)

31 July 2017

1 reference

title

Apolipoprotein E polymorphisms and concentration in chronic diseases and drug responses (English)

1 reference

31 July 2017

Sophie Visvikis-Siest

7

object named as

S Visvikis

1 reference

31 July 2017

G Siest

1

1 reference

31 July 2017

P Bertrand

2

1 reference

31 July 2017

B Herbeth

3

1 reference

31 July 2017

M Vincent-Viry

4

1 reference

31 July 2017

F Schiele

5

1 reference

31 July 2017

C Sass

6

1 reference

31 July 2017

language of work or name

1 reference

1 September 2000

1 reference

Clinical Chemistry and Laboratory Medicine

31 July 2017

1 reference

31 July 2017

38

1 reference

31 July 2017

9

1 reference

31 July 2017

841-852

1 reference

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology

31 July 2017

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.122

Overexpression and accumulation of apolipoprotein E as a cause of hypertriglyceridemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.122

Hormonal regulation of human apolipoprotein E gene expression in HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.122

Novel mechanism for defective receptor binding of apolipoprotein E2 in type III hyperlipoproteinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.122

The role of apolipoprotein E genetic variants in lipoprotein disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.122

Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.122

Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.122

A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.122

A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.122

Lack of independent associations of apolipoprotein E promoter and intron 1 polymorphisms with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.122

Analysis of association at single nucleotide polymorphisms in the APOE region.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.122

Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.122

ApoE polymorphism accounts for only part of the genetic variation in quantitative ApoE levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.122

Impact of apolipoprotein E genotype variation on means, variances, and correlations of plasma lipid, lipoprotein, and apolipoprotein traits in octogenarians

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.122

Evidence that the apolipoprotein E-genotype effects on lipid levels can change with age in males: a longitudinal analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.122

Apolipoprotein E polymorphism in middle-aged Belgian men: phenotype distribution and relation to serum lipids and lipoproteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.122

Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.122

The number of trait loci in late-onset Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.122

Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.122

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.122

Apolipoprotein E polymorphism and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.122

Decreased frequency of apolipoprotein E epsilon4 allele from Northern to Southern Europe in Alzheimer's disease patients and centenarians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.122

A novel mutation in the apolipoprotein E gene (APOE*4 Pittsburgh) is associated with the risk of late-onset Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.122

Increased plasma apolipoprotein E (apoE) levels in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.122

Serum apolipoprotein E level is not increased in Alzheimer's disease: the Rotterdam study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.122

Elevated low-density lipoprotein in Alzheimer's disease correlates with brain abeta 1-42 levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.122

Plasma levels of apolipoprotein E and genetic markers in elderly patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.122

Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.122

Bone fracture history and prospective bone fracture risk of hemodialysis patients are related to apolipoprotein E genotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.122

Does apolipoprotein E genotype relate to BMD and bone markers in postmenopausal women?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.122

Effects of probucol on plasma lipids and lipoproteins in familial hypercholesterolemic patients with and without apolipoprotein E4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.122

The influence of apolipoprotein E phenotype on the response to lovastatin therapy in patients with heterozygous familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.122

Effect of fenofibrate treatment on plasma lipoprotein lipids, high-density lipoprotein cholesterol subfractions, and apolipoproteins B, AI, AII, and E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.122

Liver-directed gene transfer and prolonged expression of three major human ApoE isoforms in ApoE-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.122

Genes, variation of cholesterol and fat intake and serum lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.122

Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.122

ApoE-epsilon 4 allele and susceptibility to drug-induced memory impairment in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.122

Effect of gender and apolipoprotein E genotype on response to anticholinesterase therapy in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.122

APOE genotyping and response to drug treatment in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.122

Donepezil therapy in clinical practice: a randomized crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.122

Combined tacrine and estrogen replacement therapy in patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.122

Association of apolipoprotein (Apo)E genotype with plasma apo E levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.122

Plasma apolipoprotein A-I, A-II, B, E and C-III containing particles in men with premature coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.122

Independent association of an APOE gene promoter polymorphism with increased risk of myocardial infarction and decreased APOE plasma concentrations--the ECTIM Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.122

Apolipoprotein E Polymorphism: A New Genetic Marker of Hip Fracture RiskThe Study of Osteoporotic Fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.122

Apolipoprotein E Gene Polymorphism and Bone Loss: Estrogen Status Modifies the Influence of Apolipoprotein E on Bone Loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.122

21 January 2018

Identifiers

DOI

10.1515/CCLM.2000.122

1 reference

31 July 2017

1 reference